Masked uncontrolled hypertension in CKD

Journal of the American Society of Nephrology

Volumn 27, Issue 3, 2016, Pages 924-932

  Agarwal, Rajiv ^a   Pappas, Maria K ^a   Sinha, Arjun D ^a  

^a RICHARD L ROUDEBUSH VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIHYPERTENSIVE AGENT; CREATININE; EPIDERMAL GROWTH FACTOR;

AGED; AMBULATORY MONITORING; AREA UNDER THE CURVE; ARTICLE; BLOOD PRESSURE MONITORING; CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HOME CARE; HUMAN; MAJOR CLINICAL STUDY; MALE; MASKED HYPERTENSION; MASKED UNCONTROLLED HYPERTENSION; MEASUREMENT ACCURACY; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC; REPRODUCIBILITY; SYSTOLIC BLOOD PRESSURE; MIDDLE AGED; RENAL INSUFFICIENCY, CHRONIC; SELF CARE; TIME FACTOR;

AGED; AREA UNDER CURVE; BLOOD PRESSURE MONITORING, AMBULATORY; FEMALE; HUMANS; MALE; MASKED HYPERTENSION; MIDDLE AGED; PREVALENCE; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; REPRODUCIBILITY OF RESULTS; ROC CURVE; SELF CARE; TIME FACTORS;

EID: 84959934812     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2015030243     Document Type: Article

References (42)

1. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS: Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 41: 1-12, 2003
2. Coresh J, Selvin E, Stevens LA,Manzi J, Kusek JW, Eggers P, Van Lente F, Levey AS: Prevalence of chronic kidney disease in the United States. JAMA 298: 2038-2047, 2007
3. Coresh J, Wei GL, McQuillan G, Brancati FL, Levey AS, Jones C, Klag MJ: Prevalence of high blood pressure and elevated serum creatinine level in the United States: findings from the third National Health and Nutrition Examination Survey (1988-1994). Arch InternMed 161: 1207-1216, 2001
4. Klahr S, Levey AS, Beck GJ, Caggiula AW, Hunsicker L, Kusek JW, Striker G; Modification of Diet in Renal Disease Study Group: The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. N Engl J Med 330: 877-884, 1994
5. Agodoa LY, Appel L, Bakris GL, Beck G, Bourgoignie J, Briggs JP, Charleston J, CheekD, ClevelandW, Douglas JG, DouglasM,Dowie D, FaulknerM, Gabriel A,Gassman J, Greene T,Hall Y, Hebert L, Hiremath L, Jamerson K, Johnson CJ, Kopple J, Kusek J, Lash J, Lea J, Lewis JB, Lipkowitz M,Massry S,Middleton J, Miller ER III, Norris K, O'Connor D, Ojo A, Phillips RA, Pogue V, Rahman M, Randall OS, Rostand S, Schulman G, Smith W, Thornley-Brown D, Tisher CC, Toto RD, Wright JT Jr, Xu S; AfricanAmerican Study of KidneyDisease andHypertension (AASK) StudyGroup: Effect of ramipril vs amlodipine on renal outcomes in hypertensive nephrosclerosis: a randomized controlled trial. JAMA 285: 2719-2728, 2001
6. Ruggenenti P, Perna A, Gherardi G, Garini G, Zoccali C, Salvadori M, Scolari F, Schena FP, Remuzzi G: Renoprotective properties of ACEinhibition in non-diabetic nephropathies with non-nephrotic proteinuria. [see comments] Lancet 354: 359-364, 1999
7. Vita JA, Keaney JF Jr, Larson MG, Keyes MJ, Massaro JM, Lipinska I, Lehman BT, Fan S, Osypiuk E, Wilson PW, Vasan RS, Mitchell GF, Benjamin EJ: Brachial artery vasodilator function and systemic inflammation in the FraminghamOffspring Study. Circulation 110: 3604-3609, 2004
8. Liu JE, RomanMJ, Pini R, Schwartz JE, Pickering TG, Devereux RB: Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure. Ann Intern Med 131: 564-572, 1999
9. Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B, Menard J, Mallion JM: Cardiovascular prognosis of masked hypertension detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA 291: 1342-1349, 2004
10. Verberk WJ, Kessels AG, de Leeuw PW: Prevalence, causes, and consequences of masked hypertension: a meta-analysis. Am J Hypertens 21: 969-975, 2008
11. Bangash F, Agarwal R: Masked hypertension and white-coat hypertension in chronic kidney disease: a meta-analysis. Clin J Am Soc Nephrol 4: 656-664, 2009
12. Cuspidi C, Sala C, Tadic M, Rescaldani M, De Giorgi GA, Grassi G, Mancia G: Untreated masked hypertension and carotid atherosclerosis: a meta-analysis. Blood Press 24: 65-71, 2015
13. Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R: Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension 47: 846-853, 2006
14. Bobrie G, Clerson P,Ménard J, Postel-Vinay N, Chatellier G, Plouin PF: Masked hypertension: a systematic review. J Hypertens 26: 1715-1725, 2008
15. Pierdomenico SD, Cuccurullo F: Prognostic value of white-coat and masked hypertension diagnosed by ambulatory monitoring in initially untreated subjects: an updated meta analysis. Am J Hypertens 24: 52-58, 2011
16. Björklund K, Lind L, Zethelius B, Andrén B, Lithell H: Isolated ambulatory hypertension predicts cardiovascular morbidity in elderly men. Circulation 107: 1297-1302, 2003
17. Fagard RH, Cornelissen VA: Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis. J Hypertens 25: 2193-2198, 2007
18. Stergiou GS, Asayama K, Thijs L, Kollias A, Niiranen TJ, Hozawa A, Boggia J, Johansson JK, Ohkubo T, Tsuji I, Jula AM, Imai Y, Staessen JA; International Database on HOme blood pressure in relation to Cardiovascular Outcome (IDHOCO) Investigators: Prognosis of whitecoat andmasked hypertension: International Database of HOme blood pressure in relation to CardiovascularOutcome. Hypertension 63: 675-682, 2014
19. Minutolo R, Gabbai FB, Agarwal R, Chiodini P, Borrelli S, Bellizzi V, Nappi F, Stanzione G, Conte G, De Nicola L: Assessment of achieved clinic and ambulatory blood pressure recordings and outcomes during treatment in hypertensive patients with CKD: a multicenter prospective cohort study. Am J Kidney Dis 64: 744-752, 2014
20. Minutolo R, Agarwal R, Borrelli S, Chiodini P, Bellizzi V, Nappi F, Cianciaruso B, Zamboli P, Conte G, Gabbai FB, De Nicola L: Prognostic role of ambulatory blood pressure measurement in patients with nondialysis chronic kidney disease. Arch Intern Med 171: 1090-1098, 2011
21. Mitsnefes M, Flynn J, Cohn S, Samuels J, Blydt-Hansen T, Saland J, Kimball T, Furth S, Warady B; CKiD Study Group:Masked hypertension associates with left ventricular hypertrophy in children with CKD. J Am Soc Nephrol 21: 137-144, 2010
22. Okada T, Nakao T, Matsumoto H, Nagaoka Y, Tomaru R, Iwasawa H, Wada T: Prognostic significance of home blood pressure control on renal and cardiovascular outcomes in elderly patients with chronic kidney disease. Hypertens Res 32: 1123-1129, 2009
23. Pogue V, RahmanM, LipkowitzM, Toto R,Miller E, FaulknerM, Rostand S, Hiremath L, SikaM, Kendrick C, Hu B, Greene T, Appel L, Phillips RA; African American Study of Kidney Disease and Hypertension Collaborative Research Group: Disparate estimates of hypertension control from ambulatory and clinic blood pressure measurements in hypertensive kidney disease. Hypertension 53: 20-27, 2009
24. Kayrak M, Gul EE, Kaya C, Solak Y, Turkmen K, Yazici R, Guney I, Altintepe L, Turk S,Ozdemir K:Masked hypertension in renal transplant recipients. Blood Press 23: 47-53, 2014
25. Cha RH, Kim S, Ae Yoon S, Ryu DR, Eun Oh J, Han SY, Young Lee E, Ki Kim D, Kim YS: Association between blood pressure and target organ damage in patients with chronic kidney disease and hypertension: results of the APrODiTe study. Hypertens Res 37: 172-178, 2014
26. Czyzewski A, Wyzga J, Koek A: Evaluation of selected risk factors of cardiovascular diseases among patients after kidney transplantation, with particular focus on the role of 24-hour automatic blood pressure measurement in the diagnosis of hypertension: an introductory report. Ann Transplant 19: 188-198, 2014
27. Iimuro S, Imai E, Watanabe T, Nitta K, Akizawa T, Matsuo S, Makino H, Ohashi Y, Hishida A; Chronic Kidney Disease Japan Cohort Study Group: Clinical correlates of ambulatory BP monitoring among patients with CKD. Clin J Am Soc Nephrol 8: 721-730, 2013
28. Gabbai FB, Rahman M, Hu B, Appel LJ, Charleston J, Contreras G, Faulkner ML, Hiremath L, Jamerson KA, Lea JP, Lipkowitz MS, Pogue VA, Rostand SG, Smogorzewski MJ, Wright JT, Greene T, Gassman J, Wang X, Phillips RA; African American Study of Kidney Disease and Hypertension (AASK) Study Group: Relationship between ambulatory BP and clinical outcomes in patients with hypertensive CKD. Clin J Am Soc Nephrol 7: 1770-1776, 2012
29. Pickering TG,Davidson K,Gerin W, Schwartz JE:Masked hypertension. Hypertension 40: 795-796, 2002
30. Franklin SS, Thijs L, Li Y, Hansen TW, Boggia J, Liu Y, Asayama K, Björklund-Bodegård K, Ohkubo T, Jeppesen J, Torp-Pedersen C, Dolan E, Kuznetsova T, Stolarz-Skrzypek K, Tikhonoff V, Malyutina S, Casiglia E, Nikitin Y, Lind L, Sandoya E, Kawecka-Jaszcz K, Filipovsky J, Imai Y, Wang J, Ibsen H, O'Brien E, Staessen JA; International Database on Ambulatory blood pressure in Relation to Cardiovascular Outcomes Investigators: Masked hypertension in diabetes mellitus: treatment implications for clinical practice. Hypertension 61: 964-971, 2013
31. Banegas JR, Ruilope LM, de la Sierra A, de la Cruz JJ, Gorostidi M, Segura J, Martell N, García-Puig J, Deanfield J, Williams B: High prevalence of masked uncontrolled hypertension in people with treated hypertension. Eur Heart J 35: 3304-3312, 2014
32. Agarwal R: Regulation of circadian blood pressure: from mice to astronauts. Curr Opin Nephrol Hypertens 19: 51-58, 2010
33. Lurbe E, Redon J, Kesani A, Pascual JM, Tacons J, Alvarez V, Batlle D: Increase in nocturnal blood pressure and progression to microalbuminuria in type 1 diabetes. N Engl J Med 347: 797-805, 2002
34. Agarwal R, Light RP: GFR, proteinuria and circadian blood pressure. Nephrol Dial Transplant 24: 2400-2406, 2009
35. Viera AJ, Hinderliter AL, Kshirsagar AV, Fine J, Dominik R: Reproducibility of masked hypertension in adults with untreated borderline office blood pressure: comparison of ambulatory and home monitoring. Am J Hypertens 23: 1190-1197, 2010
36. Ben-Dov IZ, Ben-Arie L, Mekler J, BursztynM: Reproducibility of whitecoat and masked hypertension in ambulatory BP monitoring. Int J Cardiol 117: 355-359, 2007
37. Kawabe H, Saito I: Reproducibility of masked hypertension determined from morning and evening home blood pressure measurements over a 6-month period. Hypertens Res 30: 845-851, 2007
38. Agarwal R, Light RP: Physical activity and hemodynamic reactivity in chronic kidney disease. Clin J Am Soc Nephrol 3: 1660-1668, 2008
39. Kario K, Pickering TG, Umeda Y, Hoshide S, Hoshide Y, Morinari M, Murata M, Kuroda T, Schwartz JE, Shimada K: Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives: a prospective study. Circulation 107: 1401-1406, 2003
40. Agarwal R, Andersen MJ: Prognostic importance of clinic and home blood pressure recordings in patients with chronic kidney disease. Kidney Int 69: 406-411, 2006
41. Asayama K, Thijs L, Brguljan-Hitij J, Niiranen TJ, Hozawa A, Boggia J, Aparicio LS, Hara A, Johansson JK, Ohkubo T, Tzourio C, Stergiou GS, Sandoya E, Tsuji I, JulaAM, Imai Y, Staessen JA; International Database of Home Blood Pressure in Relation to Cardiovascular Outcome (IDHOCO) investigators: Risk stratification by self-measured home blood pressure across categories of conventional blood pressure: a participant-level meta-analysis. PLoS Med 11: e1001591, 2014
42. Franklin SS, O'Brien E, Thijs L, Asayama K, Staessen JA: Masked hypertension: a phenomenon of measurement. Hypertension 65: 16-20, 2015